Research field (1):
Pharmaceuticals - chemistry and drug development
Research keywords (2):
有機化学
, 核酸化学
Research theme for competitive and other funds (2):
2021 - 2024 Development of therapeutic strategies for the realization of tumor suppressive microRNA replacement therapy for refractory solid tumors
2015 - 2017 RNA干渉の作用長期化を目指した新規プロドラッグ型siRNAの開発
Papers (16):
Junsuke Hayashi, Yosuke Ochi, Kota Senpuku, Shun-Ichi Wada, Fumito Wada, Mariko Harada-Shiba, Hidehito Urata. Rational design of prodrug-type apoB-targeted siRNA for nuclease resistance improvement without compromising gene silencing potency. Bioorganic & medicinal chemistry. 2024. 104. 117693-117693
Norihito Sugimoto, Junsuke Hayashi, Ryohei Funaki, Shun-Ichi Wada, Fumito Wada, Mariko Harada-Shiba, Hidehito Urata. Prodrug-Type Phosphotriester Oligonucleotides with Linear Disulfide Promoieties Responsive to Reducing Environment. Chembiochem : a European journal of chemical biology. 2023. e202300526
Shun-Ichi Wada, Akira Shibaike, Junsuke Hayashi, Hidehito Urata. Influence of Aib-Containing Amphipathic Helical Chain Length in MAP(Aib)-cRGD as Carrier for siRNA Delivery. Chemistry & biodiversity. 2022. 19. 2. e202100728